Product image of Imesol (Etoricoxib) supplied by GNH India

Imesol

Active Ingredient:
Etoricoxib
Origin:
EU

Imesol (Etoricoxib)

Etoricoxib, the active ingredient in Imesol, is a COX-2 inhibitor presented as an oral formulation for systemic use. It is indicated for the management of inflammatory joint disorders and acute pain in adult patients.

GNH India supplies Imesol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Terapia S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Imesol (etoricoxib) belongs to the COX‑2 selective NSAID class and is used to treat inflammatory and painful musculoskeletal conditions.

  • Osteoarthritis: reduces joint pain and improves functional mobility.
  • Rheumatoid arthritis: alleviates inflammation and joint swelling.
  • Ankylosing spondylitis: diminishes spinal stiffness and pain.
  • Acute pain: provides rapid analgesia for short‑term severe pain.
  • Dental pain: controls postoperative dental discomfort.

How It Works

  • Etoricoxib selectively inhibits the cyclooxygenase‑2 (COX‑2) enzyme, which is responsible for converting arachidonic acid to prostaglandins involved in inflammation, pain, and fever. By sparing COX‑1, the drug maintains normal platelet function and gastric mucosal protection while reducing pathological prostaglandin synthesis, resulting in anti‑inflammatory, analgesic, and antipyretic effects.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Gastrointestinal discomfort: mild nausea, dyspepsia, or abdominal pain.
  • Headache: transient tension‑type headaches.
  • Edema: peripheral swelling, especially of the lower limbs.

Serious or Rare Side Effects

  • Cardiovascular thrombotic events: increased risk of myocardial infarction or stroke.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Gastrointestinal ulcer or bleeding: serious bleeding in the stomach or intestines.

Precautions & Warnings

Patients should be evaluated for individual risk factors before initiating therapy.

  • Cardiovascular risk assessment: consider history of heart disease before use.
  • Blood pressure monitoring: check regularly during treatment.
  • Renal and hepatic function: evaluate baseline labs and monitor periodically.
  • Elderly caution: start at the lowest effective dose and monitor for adverse effects.
  • Hypersensitivity avoidance: discontinue if signs of allergic reaction appear.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Etoricoxib may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Warfarin: increased bleeding risk.
  • Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal and cardiovascular toxicity.
  • Anticoagulants (e.g., dabigatran): potential for severe bleeding.
  • Lithium: elevated lithium serum concentrations.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: possible reduction in antihypertensive effect.
  • Diuretics: risk of renal function decline.
  • Methotrexate: may increase methotrexate levels and toxicity.

Frequently Asked Questions

Imesol contains etoricoxib, a selective COX‑2 inhibitor that is prescribed for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain episodes, and dental pain. It works by reducing inflammation and pain in these musculoskeletal and short‑term pain conditions.

Etoricoxib blocks the cyclooxygenase‑2 enzyme, which is responsible for producing prostaglandins that cause inflammation, pain, and fever. By selectively inhibiting COX‑2 while sparing COX‑1, it lowers pathological prostaglandin levels without significantly affecting normal platelet function or gastric protection.

The appropriate dose of Imesol is determined by the prescribing healthcare professional based on the patient’s condition, severity, and individual risk factors. Dosage decisions should follow the prescriber’s instructions and local regulatory guidelines.

The safety of etoricoxib in pregnancy or while breastfeeding has not been fully established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To request Imesol, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Imesol (etoricoxib) is a COX‑2 selective NSAID, which generally offers lower gastrointestinal risk compared with non‑selective NSAIDs such as ibuprofen or naproxen. However, it may carry a higher cardiovascular risk profile, so clinicians balance these factors when selecting therapy.

Imesol should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat, and direct sunlight to maintain its stability and potency.

Imesol is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks include cardiovascular events such as heart attack or stroke, severe gastrointestinal bleeding or ulceration, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should be monitored for these events, especially if they have pre‑existing risk factors.

Imesol is contraindicated in individuals with known hypersensitivity to etoricoxib or any COX‑2 inhibitor, in patients with active cardiovascular disease, and in those with a history of serious gastrointestinal bleeding. It should also be avoided in patients with severe hepatic or renal impairment unless specifically directed by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Etoricoxib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT